Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum International Stem Cell Corp ISCO

International Stem Cell Corporation is a clinical-stage biotechnology company that is focused on therapeutic and biomedical product development. The Company is primarily a research and development company, for the therapeutic market, which has focused on advancing potential clinical applications of human parthenogenetic stem cells (hpSCs) for the treatment of various diseases of the central... see more

Bullboard (OTCQB:ISCO)

View:
Post by MissionIRon May 20, 2016 4:42pm

International Stem Cell Corp. (ISCO) Introducing a New Era o

International Stem Cell Corp. (ISCO) Introducing a New Era of Medicine with its First Phase of Clinical Trials    International Stem Cell Corporation (OTCQB: ISCO) is a biotechnology ...more  
Post by MissionIRon May 17, 2016 4:12pm

International Stem Cell Corporation (ISCO) Reports Operating

International Stem Cell Corporation (ISCO) Reports Operating Results for First Quarter of 2016   Before the opening bell, International Stem Cell Corporation (OTCQB: ISCO) announced its ...more  
Post by MissionIRon May 11, 2016 5:42pm

International Stem Cell Corporation (ISCO) passes another Mi

International Stem Cell Corporation (ISCO) passes another Milestone in its Quest for a Parkinson’s Cure    On March 7, 2016, International Stem Cell Corporation (OTCQB: ISCO) announced ...more  
Post by MissionIRon May 04, 2016 5:30pm

International Stem Cell Corporation (ISCO) Pushing Forward w

International Stem Cell Corporation (ISCO) Pushing Forward with Regenerative Therapies    There is scant doubt that International Stem Cell Corporation’s (OTCQB: ISCO) attention and ...more  
Post by MissionIRon Apr 27, 2016 6:33pm

International Stem Cell Corporation (ISCO) Continues Upward

International Stem Cell Corporation (ISCO) Continues Upward Climb with Two Successful Subsidiaries    A pioneer in regenerative medicine, International Stem Cell Corporation (OTCQB: ISCO ...more  
Post by MissionIRon Apr 20, 2016 5:17pm

International Stem Cell Corporation (ISCO) plans a Mutiny in

International Stem Cell Corporation (ISCO) plans a Mutiny in Organ Transplant with its Immune-Matched hpSCs   It is generally accepted that the first successful organ transplant was the one ...more  
Post by MissionIRon Apr 13, 2016 5:24pm

International Stem Cell Corporation (ISCO) Leads while Regen

International Stem Cell Corporation (ISCO) Leads while Regenerative Medicine Becomes a Global Interest   A publicly-traded biotech company, International Stem Cell Corporation (OTCQB: ISCO ...more  
Post by MissionIRon Apr 01, 2016 6:56pm

International Stem Cell Corp. (ISCO) Bypasses the Moral Dile

International Stem Cell Corp. (ISCO) Bypasses the Moral Dilemma Associated with Stem Cells   Human embryonic stem cells typically come from fertilized eggs. International Stem Cell Corp ...more  
Post by MissionIRon Mar 31, 2016 6:02pm

International Stem Cell Corporation (ISCO) Offers Business U

International Stem Cell Corporation (ISCO) Offers Business Update and Year-End Financial Results    Before the opening bell, International Stem Cell Corporation (OTCQB: ISCO) provided a ...more  
Post by MissionIRon Mar 24, 2016 7:48pm

International Stem Cell Corporation (ISCO) Developing Therap

International Stem Cell Corporation (ISCO) Developing Therapeutic and Biomedical Products on a Global Scale   International Stem Cell Corporation (OTCQB: ISCO) is a company focused on the ...more  
Post by MissionIRon Mar 17, 2016 6:06pm

International Stem Cell Corp.’s (ISCO) Virgin Birth Technolo

International Stem Cell Corp.’s (ISCO) Virgin Birth Technology holds the Promise of Stemming Progress of Parkinson’s Disease   We are apt to scoff at stories of virgin birth, and the term ...more  
Post by MissionIRon Mar 10, 2016 4:09pm

International Stem Cell Corporation’s (ISCO) Mission to Trea

International Stem Cell Corporation’s (ISCO) Mission to Treat Parkinson’s Disease Coming into Focus   International Stem Cell Corporation (OTCQB: ISCO) builds shareholder value through its ...more  
Post by MissionIRon Mar 10, 2016 3:45pm

International Stem Cell Corporation (ISCO) Enters Definitive

International Stem Cell Corporation (ISCO) Enters Definitive Agreement to Raise $6.3 Million to Fund Clinical Trial    Before the opening bell, International Stem Cell Corporation (OTCQB ...more  
Post by MissionIRon Mar 07, 2016 4:31pm

International Stem Cell Corporation (ISCO) Commences Enrollm

International Stem Cell Corporation (ISCO) Commences Enrollment of Phase I Trial of ISC-hpNSC    Before the opening bell, International Stem Cell Corporation (OTCQB: ISCO) took a major ...more  
Post by MissionIRon Mar 03, 2016 5:43pm

International Stem Cell Corp. (ISCO): Benefits of Stem Cells

International Stem Cell Corp. (ISCO): Benefits of Stem Cells Outlined in Israel/California Collaboration   In a recent article on the Jewish Journal website (https://dtn.fm/DhxK8), doctors ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities